thi applic nsi dental pti limit nsi file juli seek declar order univers melbourn univers recald pti ltd recald made unjustifi threat within patent act cth act 
injunct relief sought respect threat 
the allegedli unjustifi threat also said contraven Pt V trade practic act cth tpa equival provis fair trade act nsw 
In june solicitor univers recald sent letter third parti assert product sold nsi sinc name topac dentac infring number patent own univers 
these letter claim constitut unjustifi threat 
the patent letter refer phosphopeptid patent dental calculu patent dentin hypersensit patent complex patent 
these patent date june march expiri date rang june march 
In respons applic univers recald file nsi name entiti nsi parti infring cari inhibit patent expir march dental calculu patent dentin hypersensit patent complex patent infring manufactur sale distribut topac dentac dentac phoscal powder nsi product 
the also alleg conduct contraven tpa 
the claim infring dental calculu patent abandon univers recald decemb 
the current infring second further amend file juli 
the amend make addit assert nsi product infring phosphopeptid patent 
In respons infring nsi file challeng valid patent univers recald base claim infring invalid 
the particular invalid set nsi fifth further amend particular invalid file court decemb 
As result admiss undertak made nsi purpos proceed invalid concern complex patent 
the hear evid matter commenc novemb conclud decemb 
oral submiss close heard decemb 
the hear limit question liabil remedi 
the question quantum pecuniari relief determin separ 
issu admiss undertak made nsi parti decemb 
As consequ follow matter longer disput the phosphopeptid patent valid infring 
b the dentin hypersensit patent valid infring 
c the cari inhibit patent valid infring 
the nsi parti liabl pay damag account profit made respect manufactur sale distribut topac dentac phoscal powder 
e some nsi parti engag mislead decept conduct alleg infring 
f some nsi parti liabl pay damag account profit receiv result make said misrepresent 
the follow matter remain disput the valid claim complex patent 
nsi assert claim invalid want fair basi lack clariti ambigu want novelti lack invent step 
b the valid claim 
nsi assert claim invalid basi fals suggest 
c infring claim complex patent nsi parti result manufactur sale distribut topac dentac phoscal powder 
infring certain nsi parti complex patent result conduct fall within act 
e unjustifi threat infring univers recald 
f infring nsi parti Pt V tpa 
the patent the univers own patent refer 
the name inventor five patent professor eric reynold AO employ univers school dentistri 
each patent reflect professor reynold work univers biochemist investig chemistri milk 
In particular patent draw professor reynold work casein princip protein milk respons benefici effect milk teeth 
professor reynold carri research year result grant number patent 
the first patent grant cari inhibit patent applic respect specif origin file march 
thi patent state phosphoryl amino acid residu casein polypeptid casein effect 
the phosphopeptid patent grant relat particular phosphoryl polypeptid casein phosphopeptid particular phosphopeptid includ sequenc three phosphoryl peptid amino acid residu follow two residu amino acid differ type cluster sequenc 
the next patent grant dental calculu patent follow dental hypersenst patent subsequ grant 
thi patent relat product design treat dental hypersensit activ compon phosphopeptid contain cluster sequenc 
the complex patent princip patent suit file march prioriti date 
It relat novel chemic complex solubl alkalin amorph calcium phosphat form pH stabilis phosphopeptid 
that patent also relat composit contain complex method make complex applic complex 
the complex deliv calcium phosphat prevent dental cari tooth decay 
the nsi parti there disput appropri parti relief grant also whether claim lack novelti due prior exposur 
It therefor appropri briefli consid histori commercialis invent describ parti concern process 
around univers began enter arrang commercialis patent 
the univers enter agreement bonlac food limit bonlac australian dairi compani purpos bonlac make phosphopeptid claim phosphopeptid patent casein suppli ingredi third parti would licens use manufactur product 
In late bonlac began trial manufactur ingredi name calpep 
By calpep compris phosphopeptid cluster sequenc also phosphopeptid complex calcium phosphat 
thi complex describ detail complex patent 
bonlac engag ici australia pti ltd ici assist market calpep third parti license 
the princip contact ici Mr michael nunn 
bonlac also recruit assist new zealand pharmaceut limit nzp member ici group compani global expertis manufactur suppli ingredi made milk 
the princip contact nzp Dr richard garland 
Mr nunn employ ici nation busi manag consum specialti divis 
from respons market develop calpep product activ ingredi employ phosphopeptid technolog develop professor reynold 
In Mr nunn commenc busi known michael nunn associ 
from Mr nunn work consult nzp assist sale market phosphopeptid technolog develop univers 
Mr nunn give evid arrang dissemin introduc calpep inform said nsi repres anticip claim complex patent 
the univers submit introduc calpep inform either alon part inform packag contain disclosur complex claim claim complex patent complex 
the univers also contend dissemin Mr nunn breach oblig confid owe univers 
sinc Mr nunn director nzph australia pti ltd nzph third 
from august march nzph known nsi dental pti ltd 
Mr nunn also director phoscal hold pti ltd phoscal hold fifth decemb june 
sinc approxim januari probiotec australia pti ltd probiotec sixth manag control phoscal hold pti ltd own signific number share compani 
Dr garland director nzp sinc 
from octob Dr garland close involv market develop calpep 
after octob nzp ceas authoris involv univers technolog 
nzp howev compani manufactur phoscal powder new zealand 
Dr garland also director nzph phoscal hold 
the second topac pti ltd 
topac pti ltd known nsi dental pti ltd februari august known nulit system intern pti ltd nulit 
nulit one third parti interest technolog develop univers 
from nulit engag evalu possibl use calpep product dental applic 
nulit also manufactur product incorpor calpep suppli univers bonlac call topac calpep 
Mr lindsay mceachern director nulit 
Mr mceachern also director phoscal hold septemb june pacif biolink pti ltd pacif biolink fifth octob juli 
nsi ultim successor busi nulit 
nsi first market product subject threat univers recald 
the agreement refer univers bonlac end 
recald enter exclus licenc agreement univers 
It alleg recald particip make threat nsi therefor parti infring 
the nsi product the nsi product disput phoscal powder topac dentac 
phoscal powder made least sinc nzp tatua nutrit divis tatua dairi Co ltd 
neither compani parti proceed 
It admit nsi either agent offer suppli suppli phoscal powder australia 
It admit earli topac pti ltd obtain suppli phoscal powder australian manufactur earli nzph suppli phoscal powder australian confectionari manufactur inclus ingredi sweet 
pacif biolink licens phoscal hold entiti manufactur suppli phoscal powder australia 
probiotec contract provid manufactur servic nsi 
the exist phoscal powder product nsi made known univers interlocutori applic made compel product relev document 
topac made two form calplex phoscal 
An earlier form product known topac 
the nsi parti ceas distribut topac calplex topac undertaken futur 
further refer topac judgment topac phoscal 
the nsi parti admit august march nzph either agent manufactur suppli sold offer sale topac 
nsi either agent manufactur suppli sold offer sale topac australia sinc april 
dentac liquid form market mouth rins 
the nsi parti admit august march nzph either agent manufactur suppli sold offer sale dentac dentist pharmaci consum australia 
dure period pacif biolink also licens phoscal hold nzph manufactur suppli sell topac dentac australia 
A number admiss made nsi parti regard nsi product 
these includ follow topac dentac contain activ ingredi known phoscal 
b phoscal powder form activ ingredi known phoscal 
c phoscal stabl alkalin calcium phosphat complex 
phoscal form pH greater 
e the calcium phosphat phoscal amorph 
f phoscal includ protein includ amino acid sequenc ser P P P sequenc 
the complex patent specif the complex patent specif entitl calcium phosphopeptid complex specif 
the introductori paragraph state the present invent relat novel complex amorph calcium phosphat stabil phosphopeptid 
these complex effect may also use dietari supplement increas calcium heal prevent diseas associ calcium defici 
method make complex invent treatment prevent dental cari calcium malabsorpt bone diseas also provid 
the complex describ patent use deliv form calcium phosphat surfac teeth incorpor teeth order prevent treat dental cari 
It said meet need agent supplement effect fluorid lower incid tooth decay 
the protein casein compon respons effect dairi product 
howev use casein fight dental decay produc advers effect requir high level effect 
initi research indic casein phosphopeptid produc tryptic process contribut activ casein 
In particular phosphopeptid contain cluster sequenc use combin calcium phosphat shown produc properti 
later research indic cluster sequenc within phosphopeptid abil stabilis weight amorph form calcium phosphat 
the complex therefor solubl alkalin form calcium phosphat 
It effect form calcium phosphat lessen tooth decay effect readili deliver teeth avail carri function 
the specif goe describ requir method form complex 
claim includ claim primari focu proceed chemic complex simplicit 
that say claim product particular use complex 
claim method make complex without indic particular applic 
the remain claim mixtur claim product includ one complex claim method use product 
Of claim suit claim product includ speci claim claim method treat dental cari use speci claim 
the open word specif identifi complex subject claim 
claim reflect product claim refer product dental applic applic relev condit might result calcium defici 
the univers accept claim invalid claim 
It common ground invent lie make identifi complex rather inclus complex particular product particular purpos 
the basi invent unexpect abil cluster sequenc within phosphopeptid stabil amorph calcium phosphat prevent crystallis amorph calcium phosphat 
construct legal principl the principl construct patent specif 
the gener approach summaris full court feder court jupit ltd v neurizon pti limit ipr 
It necessari repeat full court comment 
In construct patent claim ordinari mean languag select defin claim prime import see baygol pti ltd v foamex polystyren pti ltd ipr 
although claim must understood light context whole specif gener rule word claim alter gloss taken bodi specif essenti integ determin common sens assess word claim convey context exist publish knowledg time see rehm pti ltd v webster secur system intern pti ltd alr australia pti ltd v arico trade intern pti ltd hca clr 
It legitim narrow expand boundari anomali fix word claim ad word drawn part specif see flexibl steel lace Co v beltreco ltd ipr 
In addit claim constru refer actual intent opinion inventor see sarta No pti limit v koukour partner pti ltd ipr 
It howev necessari guard unduli strict liter approach sinc circumst approach may inappropri 
By way illustr see catnic compon ltd v hiller smith ltd rpc per lord diplock 
that case illustr circumst strict liter approach consid hous lord inappropri 
construct OF claim with principl mind I turn construct claim present case 
the construct question present case focus claim complex patent 
As discuss claim claim complex product method product 
It claim monopoli A stabl solubl alkalin calcium phosphat complex form pH greater includ phosphopeptid stabilis amorph calcium phosphat deriv thereof wherein said phosphopeptid includ amino acid sequenc ser P P P 
professor daw explain claim way 
He point complex combin two compon interact compon 
the calcium phosphat complex claim alkalin 
thi mean exist pH 
there addit integ calcium phosphat must form pH greater 
thi goe manufactur complex must retain pH greater creation examin 
the phosphopeptid refer chain amino acid phosphoryl amino acid 
the phosphopeptid stabilis calcium phosphat form inhibit convert crystallin form precipit solut 
amorph calcium phosphat usual stabl tend convert crystallin form calcium phosphat 
amorph calcium phosphat dissolv releas calcium phosphat deposit teeth 
the calcium phosphat ion due size diffus surfac enamel cari lesion 
the pore surfac enamel larger charg ion imped diffus calcium phosphat ion enamel 
By contrast crystallin form calcium phosphat present mouth normal oral condit diffus teeth crystal larg diffus pore enamel 
these form calcium phosphat therefor 
the case nsi matter languag subject claim complex refer defin claim 
nsi say complex requir stabl solubl alkalin includ calcium phosphat form pH greater includ phosphopeptid stabilis amorph calcium phosphat deriv thereof 
In view last descriptor refer nsi accur reflect claim 
the final element claim refer phosphopeptid stabil amorph calcium phosphat deriv thereof 
It stabil amorph calcium phosphat deriv includ mere phosphopeptid 
nsi also submit phosphopeptid must includ cluster sequenc 
nsi say common gener knowledg among relev addresse phosphopeptid contain amino acid cluster sequenc deriv protein particular casein 
nsi contend complex includ phosphopeptid doubt adject stabl solubl alkalin describ calcium complex 
It said plain read claim adject describ complex 
they qualifi refer calcium phosphat point calcium phosphat also descriptor total complex identifi one compon 
nsi note appear disagr amongst expert mean descriptor 
nsi submit claim frame defin compris particular structur 
nsi acknowledg claim includ assert constitu complex phosphopeptid calcium phosphat say someth relationship name phosphopeptid stabilis calcium phosphat part format complex 
howev nsi submit claim consid alon say noth structur amorph calcium phosphat calcium phosphat complex 
nsi say consider bodi specif confirm complex subject claim consist phosphopeptid amorph calcium phosphat provid particular structur complex 
beyond confirm calcium phosphat amorph specif indic particular compound amorph calcium phosphat includ complex claim 
nsi say specif support conclus phosphopeptid must act distinct speci present time format complex 
accord nsi specif contain teach complex particular structur incorpor alkalin amorph calcium phosphat complex 
the teach mere amorph calcium phosphat must form care deliber process concurr process format complex 
howev teach process direct produc special type amorph calcium phosphat 
therefor descript invent phosphopeptid deliber extract isol purifi whole protein 
It suffici phosphopeptid come exist consequ ongo interact chemic process 
the reason nsi advanc submiss product stabil take place breakdown casein chemic process deliber introduct phosphopeptid stabil amorph calcium phosphat manner specifi bodi specif 
they submit infring differ way stabilis effect 
the difficulti submiss requir claim constru limit requir deliber stabilis languag contain requir 
the express includ phosphopeptid stabil amorph calcium phosphat suffici wide includ result consequ particular chemic process 
the word requir must deliber stabilis rather product time examin correctli describ stabl solubl alkalin calcium phosphat complex calcium phosphat amorph stabil phosphopeptid cluster sequenc 
It violenc languag chosen assert requir deliber introduct phosphopeptid 
such view necessit insert unwarr requir amorph calcium phosphat must stabilis deliber act process 
there must cogent reason justifi substanti variat languag must regard care draft claim 
In present case reason variat introduc 
claim contrast claim outlin method produc stabl complex calcium phosphat set four step process product 
the method product essenti claim 
the bodi specif describ detail way phosphopeptid complex patent obtain 
It state phosphopeptid may sourc suggest one exampl tryptic digest casein rich protein recombin synthesi way deriv phosphopeptid provid includ core sequenc 
As amorph calcium phosphat form phosphopeptid bind nascent nuclei stabilis amorph calcium phosphat calcium phosphat complex 
without stabil amorph calcium phosphat precipit crystallin form 
It noteworthi Dr mackinlay nsi draw distinct mean obtain phosphopeptid set bodi specif word claim 
Dr mackinlay identifi method obtain phosphopeptid outlin specif name tryptic digest chemic recombin synthesi deliber method obtain particular phosphopeptid 
howev Dr mackinlay acknowledg claim indic whether phosphopeptid deliber accident extract 
there evid support implic refer phosphopeptid deliber form introduc 
there refer possibl altern method 
for exampl univers refer submiss refer bodi specif phosphopeptid deriv sourc emphasi ad 
On evid Dr holt I accept process use manufactur nsi product one calcul produc phosphopeptid 
In view Dr holt mode manufactur storag nsi product lead breakdown suscept peptid bond enzym hydrolysi 
As consequ peptid contain cluster sequenc form 
thi describ intend result process 
the refer Dr holt process hydrolysi effect casein accept opinion formul product lead hydrolysi yield peptid contain cluster sequenc 
therefor even contrari view claim contain integ requir deliber process use lead isol cluster sequenc use stabilis amorph calcium phosphat evid Dr holt establish like within contempl nsi parti consequ process 
the second issu construct whether nsi contend requir moment complex form must stabilis phosphopeptid 
the import question nsi submiss correct amorph calcium phosphat said stabilis phosphopeptid moment format complex infring nsi product 
the univers refer phrase includ phosphopeptid stabilis amorph calcium phosphat submit refer content complex time infring test 
thi test may time manufactur time packag time sale 
accord univers question whether complex includ amorph calcium phosphat stabilis phosphopeptid time format rather whether complex includ integ time infring test 
therefor suffici stabilis take effect partli partli format complex 
On plain grammat read word claim basi justifi insert requir moment format amorph calcium phosphat must stabilis phosphopeptid 
thi contriv construct claim 
dure make nsi product cluster peptid form bind calcium phosphat 
Dr holt said evid creation cluster peptid caus breakdown casein manufactur phoscal powder manufactur storag topac dentac 
the phosphopeptid contain cluster sequenc affect stabilis amorph calcium phosphat 
In case nsi product whole casein protein includ cluster sequenc oper bind amorph calcium phosphat produc phosphopeptid stabilis amorph calcium phosphat 
nsi contend breakdown occur process stabilis occur format form phosphopeptid stabilis rather stabilis effect relev part protein 
In view infring exampl sale infring product one look product date sale ask whether contain integ claim 
In relat nsi product evid demonstr stabl solubl alkalin calcium phosphat complex form pH greater includ phosphopeptid stabilis amorph calcium phosphat 
thi complex exist phosphopeptid deriv origin protein hydrolysi effect stabilis 
the question whether complex wherein phosphopeptid includ relev cluster sequenc 
the requir characteris complex format complex 
accordingli phrase includ phosphopeptid stabilis amorph calcium phosphat qualifi format method process 
dure process result product crystal form amorph calcium phosphat grow suffici size nucleat produc precipit 
howev peptid form make cluster prevent nucleat consequ precipit 
the process occur whole protein use 
At moment format whole protein distinct phosphopeptid hold stabilis amorph calcium phosphat prevent growth crystal 
thi result breakdown protein phosphopeptid 
I find claim focu moment format finish complex possess integ 
I also accept univers submiss claim depend sole peptid form precis digest trypsin reli presenc peptid form result process use creat nsi product 
infring the next issu whether construct claim product nsi dental infring patent 
the univers case infring depend principl purpos construct 
instead univers claim integ claim liter present combin nsi product 
the question infring larg determin refer proper construct claim see olin corpor v super cartridg Co pti ltd hca clr per gibb J 
nsi say univers construct claim correct nsi product infring claim evid includ relev form amorph calcium phosphat name stabl solubl alkalin calcium phosphat 
On hand nsi say construct claim correct nsi product infring claim complex form use phosphopeptid deliber extract isol purifi 
further extent phosphopeptid creat format complex casein calcium phosphat form phosphopeptid stabilis amorph calcium phosphat requir claim 
It therefor necessari consid evid 
accord nsi process make nsi product one haphazard creation phosphopeptid oppos deliber introduct phosphopeptid 
furthermor whilst time format complex phosphopeptid may present case may form subsequ 
accordingli random form indetermin natur way phosphopeptid creat nsi product nsi submit infring claim 
It common ground nsi parti began develop nsi product whilst commerci relationship univers 
the nsi parti clearli consciou possibl infring patent own univers endeavour work around 
thi evidenc email sent behalf Mr garland nzp Dr mcintosh phoscal hold may 
thi email outlin variou patent own univers state the main issu still whether phoscal patent cover casein phosphopeptid dispers agent 
I agre jim use casein phosphoprotein would remov doubt provid check amino acid profil peptid use I sure OK 
nsi call expert evid explain develop process nsi product provid satisfactori evid research carri cours develop 
I note nulit evalu calpep Dr bannist led technic team work toward creation topac 
Dr bannist person avail nsi best posit provid evid support submiss deliber step taken isol phosphopeptid claim 
the failur adduc evid explain nsi 
In relat phoscal powder Mr buchanon scientist nzp respons formul phoscal powder howev call give detail regard develop product 
experi conduct Mr mcinerney behalf univers decemb august 
these experi establish inclus phosphopeptid contain cluster sequenc nsi product 
the result experi set evid Mr mcinerney 
the decemb experi demonstr cluster peptid present phoscal powder dentac 
In relat topac experi demonstr casein phosphopeptid establish presenc cluster peptid 
As Mr mcinerney explain affidavit decemb mean cluster peptid topac 
professor daw Dr holt call behalf univers also explain cluster peptid may detect topac 
In event august experi disclos presenc cluster peptid phoscal powder dentac topac 
these experi also establish cluster peptid creat manufactur process 
the evid Dr holt direct way phosphopeptid form act bind calcium phosphat 
He explain peptid found nsi product act casein 
Dr holt explain octob affidavit presenc small weight percentag cluster peptid signific term bind calcium phosphat weight weight basi cluster peptid bind calcium phosphat full length casein 
He state cluster peptid found phoscal powder dentac topac condit phoscal powder manufactur condit topac dentac manufactur store lead breakdown casein product 
A secondari sourc cluster peptid nsi product like presenc trace amount cluster peptid sodium casein start materi due breakdown casein milk enzym 
As consequ breakdown cluster peptid bind calcium phosphat 
the evid Dr holt phosphopeptid continu form milk secret anim due effect enzym call plasmin effect cut casein milk time secret trace level phosphopeptid milk 
after secret plasmin continu creat phosphopeptid extent depend condit 
when milk react sodium casein produc raw casein condit encourag enzym activ plasmin creat phosphopeptid casein process hydrolysi 
In nsi product process manufactur oper make phosphopeptid remain plasmin 
therefor time format nsi product phosphopeptid present among casein react calcium phosphat complex may complex form includ phosphopeptid 
after make nsi product condit storag handl passag time precipit creation phosphopeptid enzym activ plasmin hydrolysi 
the plasmin act way leav cluster phosphopeptid intact 
accord Dr holt hydrolysi act randomli casein 
He consid case phosphopeptid result hydrolysi cluster sequenc preserv casein prevent precipit 
In opinion Dr holt two experi conduct Mr mcinerney confirm view manufactur storag condit result breakdown casein 
He also say hydrolyt effect continu phoscal 
the decemb august experi establish satisfact nsi product contain signific amount phosphopeptid contain cluster sequenc 
the evid indic activ ingredi topac stabl solubl alkalin calcium phosphat complex 
It admit nsi parti phoscal powder activ ingredi topac dentac includ stabl alkalin calcium phosphat complex 
the refer water dispers refer solubl 
claim refer complex stabl calcium phosphat remain amorph form arriv point use dissolv crystallis reach tooth 
thi stabil obtain phosphopeptid bind calcium phosphat 
It also admit nsi parti phoscal powder activ ingredi topac dentac form pH greater 
the evid satisfi nsi product includ phosphopeptid stabilis amorph calcium phosphat 
As discuss evid indic presenc phosphopeptid nsi product 
Dr holt evid phosphopeptid would stabilis amorph calcium phosphat solubl alkalin form 
professor daw call univers conclud topac dentac pharmaceut composit includ complex within claim combin pharmaceut carrier 
He consid phoscal powder pharmaceut composit includ complex place pharmaceut carrier 
It common ground claim found infring claim also infring 
In respect claim method claim nsi parti reli reason relat claim I alreadi reject reason given 
accordingli I find claim complex patent infring nsi product 
parti If claim valid nsi agre parti infring exploit three product within jurisdict 
In relat topoc includ nsi second third 
In relat dentac infring found patent valid nsi recald infring parti 
In relat phoscal relev parti nsi recald respond 
At point I propos find determin relev parti grant relief I reserv determin question parti opportun consid reason make submiss question 
I turn question novelti 
novelti legal principl for patent valid pursuant b act invent must novel compar prior art base exist prioriti date relev claim 
section act provid patent invent taken novel unless novel light specifi type inform must consid separ 
the relev type inform purpos matter prior art inform made publicli avail singl document singl act 
b inform made publicli avail two relat document though relat act relationship document person skill relev art patent area would treat singl sourc inform 
the test anticip whether use product process accord prior disclosur would constitut infring claim 
If answer affirm claim anticip invalid lack novelti see meyer taylor pti ltd v vicarr industri ltd hca clr per aickin J freseniu medic care australia pti ltd v gambro pti ltd fcafc 
thi test call consider whether prior disclosur incorpor integ claim see freseniu medic care australia pti ltd v gambro pti ltd fcafc 
that prior disclosur must reveal total invent anteced inform must person ordinari knowledg subject would perceiv understand abl practic appli invent without need experi obtain inform invent made use see hill v evan De GF J per lord westburi LC olin corpor v super cartridg Co pti ltd hca clr per stephen mason JJ 
In word princip issu whether content effect claim anticip suffici destroy element novelti invent see pharmaceut v eli lilli Co fcafc 
Of particular import whether disclosur suffici clear 
that disclosur must contain clear unmistak instruct use claim invent see pfizer oversea pharmaceut v eli lilli Co fcafc freseniu medic care australia pti ltd v gambro pti ltd fcafc 
In documentari anticip insist upon clear unmistak instruct requir equival languag claim invent disclosur 
what matter taught materi evan medic ltd patent rpc per laddi J 
the act prior public said anticip invent must publicli avail must commun member public without restraint use inform recipi see arrow pharmaceut ltd v merck Co inc alr 
A similar test outlin drummond J stanway oyster cylind pti ltd v mark ipr 
novelti the claim nsi submit claim novel therefor invalid 
the univers accept valid claim turn question claim 
the univers submit howev claim stand independ 
there three document anticip base 
these An articl sato other publish entitl characteris phosphopeptid deriv bovin beta inhibitor precipit calcium phosphat sato articl 
It assert nsi articl disclos invent claim 
b A review articl reynold publish entitl dairi product dental health reynold articl 
It assert nsi articl disclos invent claim 
c public inform includ An applic june ici nation food author australia septemb nfa applic 
It assert nsi document disclos invent claim 
ii A document entitl calpep booklet distribut univers may potenti user product manufactur bonlac limit inform packag 
It assert nsi document disclos invent claim 
the univers maintain disclosur invent made also document made publicli avail provid confidenti recipi 
nsi press claim provis professor reynold sampl topac calpep dentist australia septemb constitut prior disclosur invent 
novelti the sato articl the sato articl base experiment work prepar casein phosphopeptid beta casein 
the phosphopeptid contain cluster sequenc 
the phosphopeptid mix calcium chlorid sodium phosphat buffer pH left stand minut 
Dr mackinlay call nsi gave evid sato articl report procedur involv format complex phosphopeptid calcium phosphat nomin alkalin pH 
He said data trigger calcul inevit led conclus experi mere report calcium alon bind phosphopeptid creation complex phosphopeptid calcium phosphat therefor anticip claim 
nsi submit procedur sato articl involv format complex phosphopeptid prevent precipit calcium phosphat 
nsi say complex form procedur sato articl stabl prevent precipit 
It solubl complex made remain solut alkalin form pH greater 
nsi say sato articl therefor incorpor integ claim direct sato articl follow would inevit result product complex patent valid would constitut infring patent 
the univers point nsi led littl evid concern extent public sato articl 
nsi led formal evid fact public 
the univers say sato articl disclos invent claim evid Dr mackinlay justifi conclus sato articl anticip invent 
the univers point Dr mckinnon gave evid sato articl report measur final phosphat concentr leav role phosphat unclear 
As admit Dr mackinlay final calcul would necessari order determin whether casein phosphopeptid bind calcium phosphat 
the sato articl also make mention complex disclosur complex form 
the sato articl give inform natur composit structur entiti form casein calcium phosphat 
the relev inform provid sato articl accord Dr mckinnon amount calcium higher simpli calcium phosphat phosphopeptid 
although sato articl indic cluster present suggest may import Dr mckinnon say sato articl specifi cluster requir provid evid support import cluster 
I accept evid Dr mckinnon point 
there mention stabl alkalin complex form pH greater sinc integ miss suppli skill addresse 
further specif refer sato articl amorph calcium phosphat 
Dr mackinlay admit simpli assum calcium phosphat would take form 
although Dr mackinlay said calcul necessari agre realli understand scatchard plot figur sato articl 
He conced suffici familiar scatchard plot make necessari calcul 
A comparison plot import proper understand sato articl lack 
I consid sato articl anticip invalid patent lack novelti 
novelti the reynold articl nsi submit complex claim disclos section reynold articl entitl interact cpp calcium phosphat refer calcium phosphopeptid mark abil stabilis calcium phosphat solut 
nsi say reynold articl expressli disclos format complex 
It accept Dr holt call univers complex disclos reynold articl stabl solubl 
the remain issu whether reynold articl disclos complex form pH greater 
In submit reynold articl disclos integ claim nsi reli evid Dr holt 
nsi say Dr holt ultim accept readi infer reynold articl teach format complex alkalin pH 
nsi contend refer alkalin Dr holt must refer pH greater 
nsi submit relev distinct made complex claim form pH greater complex form pH 
It therefor follow pH essenti integ claim 
the univers contend disclosur format complex pH greater 
Dr holt opinion relev section reynold articl teach pH variou solut made 
He said reynold articl much descript experi might carri rather statement experi carri 
the reynold articl make clear pH rang concentr use form complex 
furthermor univers say reynold articl refer pH rang context experi conduct absenc phosphopeptid indic would happen presenc phosphopeptid 
In Dr mackinlay gave evid sever solut describ section reynold articl form pH pH greater 
the univers also refer section reynold articl entitl mineralis enamel lesion 
the univers say evid given Dr mackinlay establish solut refer second paragraph section bear relationship experi 
thi section mere contain statement number solut contain variou amount calcium phosphopeptid calcium phosphat creat rang final adjust pH valu 
the pH valu refer pH intermedi stage 
nowher specif format pH greater 
the absenc precis pH integ defeat anticip claim nsi base reynold articl 
the reynold articl teach pH solut made 
thi accord Dr holt evid reynold articl contain descript experi rather statement experi done consequ one sought reproduc experi would consider difficulti determin appropri rang pH concentr 
On evid reynold articl teach format stabl solubl alkalin amorph calcium phosphat complex pH greater 
I consid reynold articl anticip invalid patent lack novelti 
novelti inform packag disclosur A document entitl introduc calpep document part inform packag prepar market purpos 
A copi inform packag produc court australia new zealand food author anzfa respons subpoena 
inform similar type sent applic nation food author successor anzfa 
the document reli nsi amount anticip complex patent 
nsi say complet disclosur complex subject claim page eight ten inform packag 
nsi lead evid skill addresse way document read although professor reynold nsi 
the document refer calcium phosphopeptid complex anticariogen properti complex amorph calcium phosphat stabilis casein phosphopeptid lower risk tooth decay 
It also refer pH variou pH 
the univers acknowledg refer page document neutral alkalin 
solut howev say refer properti solut method manufactur 
the univers say document goe teach method manufactur complex pH assess efficaci complex made pH 
thi clearli outsid claim complex patent requir format complex pH greater 
the document goe discuss rat studi human situ studi 
the rat studi expressli refer pH manufactur 
howev rat studi appear refer solut use human studi 
thi solut sodium phosphat solut form pH 
there numer refer document solut form pH 
there singl refer solut form pH page document howev conclus page refer method manufactur rat studi human situ studi name method requir sodium phosphat pH solut 
evid given professor reynold refer pH typograph error 
the relev part document extent contradictori 
howev emphasi document efficaci solut made pH 
In view regard skill reader would left confus document pH complex manufactur 
As state gener tyre rubber Co v fireston tyre rubber Co ltd rpc suffici prior disclosur contain direct capabl carri manner would infring patente claim least like carri way would infring claim 
the refer pH document describ clear unmistak direct produc complex 
professor reynold gave evid type inform document suffici enabl manufactur product 
Mr quigley refer discrep inform inform packag process actual employ product trial csiro 
the evid Mr nunn inform document would enabl manufactur calpep product without inform 
accordingli said document anticip integ claim 
public avail and consent In event I incorrect document anticip integ claim issu whether novelti destroy disclosur made publicli avail prioriti date act 
nsi bear onu establish document made publicli avail see jupit ltd v neurizon pti ltd ipr 
If establish order uphold valid patent univers must establish consent disclosur document b act 
In case I satisfi document made publicli avail also univers consent publicli disclos 
I satisfi document made avail limit bodi person circumst appear face document qualiti confid 
It appear document commun limit purpos import oblig disclos suggest reader disclosur would amount breach confid see moorgat tobacco Co ltd v philip morri ltd No hca clr 
section act provid purpos decid whether invent novel court must disregard inform made publicli avail without consent patente public anoth person deriv inform patente 
nsi contend inform packag made publicli avail evid demonstr inform packag sent professor reynold offic number prospect third parti license may includ Dr barnett smithklin beecham Ms finidori synthelabo franc Dr nelson consum health care unit state Mr markowitz block drug compani unit state Mr faller procter gambl unit state Mr ziemkiewicz chesebrough pond unit state Mr garland nzp new zealand 
the question disclosur case twofold 
the first question whether inform packag made publicli avail 
the univers claim inform packag receiv circumst oblig confid impos recipi respect content therefor disclosur inform packag disclosur peopl free law equiti use 
the second question whether univers consent inform packag made publicli avail 
In relat first question nsi submit oblig confid owe recipi 
nsi say professor reynold make complex sinc least sinc time regard detail disclos inform packag protect exist patent 
nsi also say professor reynold known may inform insuffici enabl commerci manufactur complex 
relianc place said professor reynold evid recognis special close structur said prompt applic complex patent end 
the onu show inform made publicli avail person seek revok patent 
To amount public disclosur inform must made avail person free law equiti use inform 
therefor disclosur specifi number person automat constitut public disclosur 
If disclosur inform packag suffici constitut anticip nsi prove inform made publicli avail univers must show disclosur made without consent patent applic invent made within prescrib period one year 
the univers contend refer patent applic act includ provision applic 
the languag section make distinct provision complet applic 
section make clear patent applic may provision applic 
Mr nunn call nsi 
Mr nunn qualifi experienc food scienc technolog set 
between septemb Mr nunn firm retain nzp wholli own subsidiari ici assist sale market calpep product 
At time calpep manufactur behalf bonlac bio scienc intern pti ltd subsidiari bonlac 
bonlac appoint ici nzp market complex 
Mr nunn respons assist market calpep compani food dental industri 
It market specif inclus dental product food product 
In cours work Mr nunn liais professor reynold bonlac 
He also report Dr garland manag director nzp 
In Mr nunn prepar petit affirm calpep safe product 
thi known gra document 
It contempl document might file unit state food drug administr fda 
Mr nunn respons part gra document direct compli fda regul 
professor reynold involv draft technic aspect gra document inclus requir manufactur inform 
Mr nunn use document present mid late number potenti custom interest use calpep product uncl tobi heinz johnson johnson 
copi gra document left prospect custom 
He thought use market tool prospect custom interest use complex dental product foodstuff set inform necessari one custom wish subsequ seek approv fda nation food author australia regulatori bodi product includ complex 
between late februari visit number larg oral care confectionari compani unit state europ 
these includ smithklin beechem manufactur maclean toothpast cadburi confectionari lead confectionari manufactur 
He provid compani sampl calpep provid professor reynold may ask professor reynold secretari send inform packag individu name facsimil 
these individu includ person name 
Mr nunn say section inform packag head An introduct anticariogen casein phosphopeptid larg reproduc gra document 
He refer affidavit draft evalu confidenti disclosur agreement refer correspond smithklin beecham say agreement never execut 
Mr nunn awar confidenti agreement enter oblig confid impos smithklin beecham relat inform packag 
He refer letter two larg corpor chesebrough pond usa Co 
pzfizer inc acknowledg receipt inform packag 
Mr nunn say inform professor reynold repres bonlac complex respons market potenti custom differ complex manufactur suppli march 
the evid inform packag sent person refer may direct Mr nunn 
the materi sent professor reynold secretari 
howev mean professor reynold sent materi gave consent sent 
Mr nunn say expressli told whether particular manufactur inform inform packag confidenti 
howev agre posit make determin one way confidenti inform 
In express view complet manufactur descript could confidenti 
Dr garland refer meet decemb subsequ discuss Mr nunn product inform packag 
He say meet decemb agre Mr nunn Mr quigley professor reynold would prepar inform packag complex 
He said discuss effect inform packag treat Mr nunn confidenti document 
Dr garland provid Mr botsman retain bonlac consult part inform packag refer nzp prior finalis 
He refer commerci meet state recollect indic given meet import treat calpep manufactur process describ inform packag confidenti 
He say inform materi contain inform packag could dissemin potenti custom due confidenti natur 
professor reynold univers gave evid univers bonlac held meet regular basi earli onward review progress relat aspect phosphopeptid project 
regular attende includ Mr hammermeist Mr quigley Mr botsman Mr nunn 
Mr garland also attend time time 
the meet discuss negoti bonlac relat involv project interest technolog shown third parti colgat warner lambert develop commerci process manufactur product 
professor reynold say time confidenti regular issu discuss meet 
He exhibit agenda date april list item entitl confidenti 
He also refer anoth meet octob issu confidenti rais 
professor reynold say issu also brought time time outsid meet 
He say understand meet attend variou discuss held peopl involv project involv inform awar need protect confidenti inform pertain technolog particular inform concern manufactur process 
professor reynold also gave evid univers approach compani nulit express interest evalu technolog potenti inclus one dental product 
He refer confidenti agreement univers nulit date may 
He say confidenti relat project issu regularli rais repres bonlac particularli relat provis inform concern technolog third parti 
He annex document entitl note acpp meet date june relat sign confidenti agreement 
the signatur Mr nunn appear bottom document 
professor reynold also refer receiv copi requir gra affirm Mr nunn prepar technic content draft document base requir 
the gra affirm requir inform concern manufactur process provid 
professor reynold say I accept unawar Mr nunn use gra document present potenti custom mid late 
He say unawar gra document use market tool discuss meet Mr nunn anyon els 
professor reynold state wrote sever reiter document includ titl anticariogen casein phosphopeptid includ confidenti inform manufactur process 
He believ gra applic submit fda complet licenc agreement 
professor reynold also say recal seen inform packag exhibit Mr nunn affidavit prior provid copi affidavit 
In relat inform packag professor reynold state contain error inform import understand efficaci product omit incorrectli transcrib 
He ad also contain inconsist inform relat pH complex form 
regard nfa applic professor reynold state understood applic treat confidenti least april 
Mr quigley gave evid univers 
He employ bonlac food senior project manag research develop manag 
He report Mr hammermeist group manag technolog develop 
At bonlac Mr quigley involv project relat anticariogen casein phosphopeptid technolog also known calpep 
from csiro assist bonlac carri pilot scheme 
ici origin part project team respons tri develop market technolog 
Mr quigley recal professor reynold develop calpep technolog 
He state bonlac right relat manufactur market calpep togeth univers partner project tri develop product suitabl commercialis 
He refer regular meet involv calpep project held regularli everi week intens period process develop 
these meet particularli technic natur 
Mr quigley note separ meet commerci natur relat develop market technolog also held 
Of second type meet recal gener meet involv professor reynold Mr nunn 
He also rememb attend meet professor reynold Mr nunn Mr hammermeist Mr botsman consult bonlac 
Mr garland attend occas 
Mr quigley say treat detail bonlac develop manufactur process confidenti recal disclos detail inform develop manufactur process ici nzp Mr garland Mr nunn 
He recal bonlac approach consent extern use inform packag concern manufactur process consent bonlac extern use document 
Mr quigley say materi entitl An introduct anticariogen casein phosphat peptid similar intern refer document use primer technolog circul first join calpep project 
howev recal time materi differ titl 
On march univers enter confidenti agreement bonlac victorian dairi industri author vdia regard evalu process product anticariogen phosphopeptid casein 
thi agreement provid oblig absolut secreci evalu period 
the univers subsequ enter manufactur agreement option licenc bonlac march 
thi agreement import confidenti regim earlier document 
follow anoth agreement enter univers februari involv univers vdia bonlac ici 
thi agreement also identifi impos oblig confidenti parti 
In facsimil date may Mr michael glass warner lambert evid refer confidenti agreement made june compani ici 
An amend propos warner lambert novemb ici made certain adjust busi never sign due inclus certain exclus provis 
there refer howev term confidenti clarifi agreement draft nzp 
further confidenti request also refer technolog licenc agreement finalis decemb involv univers bonlac vdia 
thi agreement impos duti state confidenti inform must use specif purpos 
In view exist agreement undertak support conclus univers prepar consent disclosur public inform concern develop process 
there agreement specif point howev histori univers concern regard confidenti period refer issu meet make like regim effect 
I satisfi Mr nunn appreci inform contain calpep document confidenti natur notwithstand assert consid complet descript manufactur process would confidenti natur 
the recipi inform packag obvious import client contact ici nunn previou discuss 
one might reason expect would treat materi confidenti face impos oblig disclos 
Dr garland report adopt posit unless expressli spelt materi disclos confidenti would infer would confidenti 
Dr garland said even case patent applic disclos purpos enter agreement would consid inform confidenti unless expressli stipul 
I accept reason tenabl view 
It also import bear mind although professor reynold secretari sent inform packag done direct Mr nunn 
I accept distribut inform known professor reynold 
have regard forego I satisfi materi inform packag made publicli avail 
In event I satisfi univers consent made publicli avail 
nation food author applic An applic made nfa ici june approv complex phosphopeptid calcium phosphat food addit inclus food market australia nfa applic 
professor reynold consult draft nfa applic discuss nfa applic use Dr garland Mr nunn basi inform packag 
the idea inform packag aros suggest made Dr garland Mr nunn use nfa applic amend market tool 
I satisfi inform packag prepar extract materi nfa applic 
the prepar inform packag supervis Dr garland 
professor reynold involv extend provid updat paper anticariogen casein phosphopeptid bonlac fact sheet 
nsi claim nfa applic made publicli avail 
It say nation food author act nfa act duti impos nfa staff consult disclos confidenti commerci inform acquir cours nfa activ 
the nfa treat inform confidenti claim commerci confidenti made applic time lodg nfa 
otherwis inform would regard part public regist access member public 
nsi say commerci confid never claim univers relat inform includ nfa applic either time nfa applic made subsequ 
therefor say inform made publicli avail 
nsi submit surpris late professor reynold alreadi make complex outlin claim substanti period time univers bonlac regard inform protect phosphopeptid patent 
nsi also add univers bonlac long way develop manufactur procedur complex sort would truli confidenti 
the univers contend nfa act impos oblig applic respect confidenti inform 
further say evid indic two applic nfa withdrawn part made avail public 
Mr nunn gave evid I accept professor reynold play import role discuss regard draft inform packag 
thi evid led late affidavit Mr nunn 
hi recollect event relat creation inform packag view 
furthermor Mr nunn claim second affidavit edit paper discuss anticariogen casein phosphopeptid professor reynold support actual diari entri suggest Mr nunn edit paper alon 
Mr nunn agre recollect event base diari entri independ recollect 
the natur Mr nunn evid also evid adher view abbrevi nda document refer agreement reason approach correct 
Dr garland oral evid particular discuss repres univers bonlac relat use document includ booklet introduc calpep market purpos 
have regard matter I persuad applic nfa amount disclosur even assum contain adequ inform would constitut anticip invent 
nsi refer fact neither Mr botsman Mr hammermeist report Mr botsman call support univers submiss oblig confid impos respect inform packag 
I persuad advers strengthen infer drawn absenc wit 
In case Mr botsman I satisfi involv prepar market materi extent alleg nsi 
In view incumb univers view evid professor reynold Mr quigley call wit 
I taken absenc account howev I consid anyth flow fact call respect issu confidenti 
invent step principl the question whether invent involv invent step compar prior art base exist prioriti date claim 
the invent taken involv invent step unless would obviou person skill relev art light common gener knowledg exist patent area march 
In minnesota mine manufactur compani v beiersdorf australia limit hca clr aickin J defin common gener knowledg known use relev trade 
It form background knowledg experi avail trade consid make new product make improv old must treat use individu gener bodi knowledg 
At outset necessari describ attribut skill addresse relev patent area 
the skill addresse legal construct assum person team imagin invent pfizer oversea pharmaceut v eli lilli Co fcafc per french lindgren JJ 
thi mean addresse technician person practic qualif 
In field chemistri addresse person group high level qualif capac origin research aktiebolaget hassl v alphapharm pti ltd hca clr 
the test formul major alphapharm whether addresse would directli led matter cours pursu one avenu expect may well produc claim result 
their honour refer approach taken graham J olin mathieson chemic corpor v biorex laborati ltd rpc 
hi honour frame question term whether notion research group relev date circumst includ knowledg relev prior art fact natur success chemic would led directli matter cours tri particular substitut expect might well produc use altern better drug exist drug bodi use purpos 
In approach question obvious necessari assess invent invent simpli examin integ isol 
In alphapharm major said the trace cours action complex detail well labori good deal trial error dead end retrac step take routin step hypothet formul taken matter cours 
thi observ pertin present case 
mere verif discoveri invent 
An invent may made brilliant sudden insight act slow labori approach see In farbenindustri AG patent rpc per maugham J 
obvious determin ask whether particular avenu research worth tri 
submiss the invent present case claim univers said resid recognit desir outcom name treatment dental cari use calcium phosphat casein provid outcom complex integ claim 
nsi submit invent claim univers claim lack invent step 
nsi say common gener knowledg prior prioriti date claim includ knowledg cluster sequenc within casein function sequenc bind calcium phosphat adjust condit complex form increas pH fact complex would form amorph calcium phosphat casein phosphopeptid 
thi common knowledg either taken separ combin make invent obviou 
the complex patent specif refer basi invent unexpect abil casein phosphopeptid contain cluster sequenc stabilis amorph calcium phosphat localis tooth surfac provid superior efficaci 
the specif state found amorph form calcium phosphat stabilis casein phosphopeptid solubl basic form calcium phosphat superior form prevent cari increas calcium 
An exampl given titrat calcium ion phosphat ion maintain pH prefer presenc phosphopeptid 
the exampl refer amorph calcium phosphat form phosphopeptid bind nuclei stabilis amorph calcium phosphat calcium phosphopeptid complex 
the phosphopeptid prevent precipit amorph calcium phosphat solut crystallin form limit anticariogen activ 
the benefit deriv complex patent aris identif cluster phosphopeptid stabilis calcium phosphat amorph solubl alkalin form 
the complex patent draw sever field expertis 
the field invent concern calcium phosphat complex stabl solubl alkalin form involv transit state call expertis calcium phosphat chemistri 
the invent step also concern interact calcium phosphopeptid call understand calcium protein 
A third area skill requir understand benefici effect calcium phosphat complex form 
nsi claim relat claim complex patent skill person must biochemist protein chemist familiar variou form bovin casein characterist includ amino acid sequenc 
the person must awar abil casein interact calcium phosphat experienc prepar peptid laboratori develop chemic entiti 
In relat claim nsi claim skill person must team consist biochemist protein chemist describ formul chemist experienc formul activ ingredi pharmaceut therapeut composit deliveri vehicl 
Dr mackinlay call nsi protein chemist retir 
the univers hand submit nsi incorrectli characteris attribut relev skill person team person 
the univers say complex patent travers number scientif disciplin includ oral biolog protein chemistri calcium phosphat chemistri includ physic chemistri 
the relev physic chemistri acknowledg Dr mackinlay 
therefor relev person person must knowledg field 
the univers contend Dr mackinlay possess necessari skill 
Dr mackinlay retir biochemist 
hi research casein ceas earli sinc work field 
He never studi interact casein calcium phosphat expertis calcium phosphat chemistri oral biolog 
Dr mackinlay conced right person give evid mean term metast term appear complex patent 
He said physic chemist would appropri person provid inform 
the univers say Dr row formul chemist call nsi abl suppli miss attribut relev skill person 
evid Dr mckinnon physic chemist call univers state understand physic chemistri issu particular chemic equilibria phase behaviour critic understand complex describ complex patent 
I accept opinion relev field clearli concern prevent chang physic state 
Dr mckinnon particular expertis physic chemistri 
thi area chemistri involv studi physic properti materi form state form chang environment condit temperatur pressur 
It also concern studi equilibria differ form matter chemic speci includ transform three differ state matter liquid solid gase investig factor affect extent rate chemic reaction 
these qualif pertin understand oper cluster sequenc phosphopeptid calcium phosphat complex 
Dr mckinnon work dairi chemistri area sinc issu phase behaviour solubl chemic equilibrium thermodynam chemic reaction 
Dr mckinnon howev experi oral biolog 
He experi work casein calcium phosphat dairi chemistri context 
hi work concentr miner composit milk interact calcium phosphat casein micel milk 
although Dr mckinnon publish wide dairi chemistri field prior prioriti date complex patent I satisfi extent experi area 
the evid Dr mckinnon Dr mackinlay consult mani author sourc indic extent overlap area expertis 
So far oral biolog concern I accept Dr daw call univers skill addresse field oral biolog 
thi case possibl reli simpli evid one skill person group exclus evid other 
there simpl exclusionari touchston 
the wit side clearli common area expertis 
howev Dr mackinlay relev attribut skill addresse Dr mackinlay Dr mckinnon I satisfi experi expertis Dr mckinnon physic chemist direct relev calcium phosphat chemistri Dr mackinlay 
accordingli I give somewhat greater weight evid Dr mckinnon skill addresse Dr mackinlay 
I howev taken account evid Dr mackinlay weigh balanc consid question obvious 
the univers submit Dr mackinlay evid must approach caution unclear precis knowledg march 
thi unclear Dr mackinlay person knew march fact assum addit knowledg gain read articl provid instruct solicitor 
the univers also submit Dr mackinlay view could influenc hindsight given copi complex patent earli litig 
taken isol decis object 
howev author show matter goe weight given Dr mackinlay evid point need exercis degre caution consid evid see exampl minnesota mine manufactur compani v beiersdorf australia limit hca clr per aickin J 
reev and latour articl nsi assert claim lack necessari invent step common gener knowledg march cluster sequenc present casein serv bind calcium phosphat 
It contend knowledg taken paper reev latour entitl calcium phosphat sequest phosphopeptid casein reev latour articl would make invent obviou skill addresse 
subject comment regard skill addresse princip relev skill addresse includ Dr mackinlay Dr mckinnon 
nsi reli evid Dr mackinlay effect reev latour articl teach casein phosphopeptid complex form ph greater 
howev Dr mackinlay conced reev latour articl mention whether complex casein phosphopeptid form use hindsight reach conclus 
thi illustr way Dr mackinlay use hindsight 
Dr mackinlay first saw reev latour articl read complex patent univers submit diminish weight given evid 
furthermor reev latour articl state cluster phosphopeptid increas solubl calcium phosphat 
the univers say conclus reach articl read conjunct articl Dr reynold entitl anticariogen calcium phosphat complex typtic casein phosphopeptid rat 
Dr mckinnon gave evid would understood reev latour articl show casein phosphopeptid could make solubl certain amount calcium phosphat would abl tell phosphopeptid interact calcium phosphat form entiti 
He consid articl enabl conclus reach structur size entiti form precis chemic composit form calcium phosphat 
nor could proport phosphopeptid calcium ion phosphat ion water determin 
all could conclud entiti would contain calcium phosphat casein phosphopeptid 
Dr reynold gave evid reev latour articl identifi cluster sequenc demonstr whether entiti includ calcium phosphat calcium phosphopeptid form result experi 
the articl also identifi calcium phosphopeptid could help solubilis calcium phosphat 
I consid expert evid wit support view reev latour articl oper make invent step obviou 
sato articl nsi reli evid Dr mackinlay effect sato articl teach casein phosphopeptid sequenc form ph greater 
howev Dr mackinlay conced sato articl describ complex casein phosphopeptid calcium phosphat indic role phosphat 
the univers claim clear Dr mackinlay read sato articl light articl Dr holt preced five year 
Dr mackinlay approach amount impermiss mosaic circumst two articl read singl sourc inform 
Dr mckinnon evid possibl deduc natur exact entiti form casein calcium phosphat articl 
there measur sato articl final phosphat concentr therefor role phosphat format entiti unclear 
In light evid I accept I consid sato articl serv make invent step obviou 
reynold articl nsi also reli reynold articl highlight Dr mackinlay consid articl teach casein phosphopeptid calcium phosphat complex form pH 
He say reynold articl indic casein phosphat contain cluster sequenc calcium phosphat amorph 
It teach format complex pH greater 
Dr mckinnon consid focu reynold articl test efficaci complex treat cari rather complex 
He consid reynold articl report cluster sequenc import form properti complex understand indic calcium phosphopeptid solut prepar contain calcium phosphat ion concentr would make solut calcium phosphat 
take evid account I consid reynold articl render invent obviou 
It import note Dr mckinnon point affidavit three articl discuss extent teach differ direct 
Dr mckinnon observ reev latour articl reynold articl contradictori relat issu stabil 
Dr mckinnon consid articl read togeth indic whether pH would hinder format stabl complex due increas likelihood precipit calcium phosphat calcium casein 
In addit professor reynold gave evid lengthi research experiment process detail step taken year arriv invent take account differ stage stream research relat format complex variou pH valu increas yield extens trial error involv consider document teach away invent 
these element import consider relat question obvious see alphapharm 
hypothet research project DR mackinlay Dr mackinlay ask nsi describ way hypothet research project hrp would gone develop chemic entiti would take advantag interact casein calcium phosphat maximum amount calcium phosphat bound 
thi base assumpt part common gener knowledg calcium phosphat bind casein 
the univers level sever critic hrp 
first univers submit Dr mackinlay opinion affect hindsight 
secondli contend hrp assum part invent process 
thirdli submit Dr mackinlay proceed wrong test obvious regard whether straightforward routin step could taken make invent 
In relat first issu univers point Dr mackinlay provid complex patent embark hrp 
As discuss author indic consider caution must exercis glare effect hindsight factor reason obvious 
As exampl Dr mackinlay refer set task work hypothesi complex sort describ claim could prepar 
Dr mckinnon hand given copi complex patent set knowledg march 
hi evid read complex patent march would expect abl prevent growth calcium phosphat size complex form stabl solut 
the reason alkalin pH calcium phosphat highli insolubl precipit rapidli 
Dr mckinnon also said read complex patent would found difficult influenc knowledg gain read read activ sinc march 
In relat second issu seen paramet hrp assum part invent process name recognit desir outcom 
the desir outcom advanc treatment dental cari use calcium phosphat casein 
the univers submit assumpt hrp lack context sens end goal given 
the univers also refer approach outlin high court alphapharm 
In case high court state question whether person group would led directli matter cours tri claim invent expect might well produc use result 
thi indic import context provid use result 
the research evalu light given purpos result direct 
Dr mckinnon said would want know purpos context hrp embark 
He said without inform would embark hrp engag Dr mackinlay lack direct definit 
In relat third issu univers submit Dr mackinlay proceed basi make adjust relat pH temperatur ionis concentr routin disclos erron approach question obvious 
the correct differ test accept alphapharm whether person would led directli matter cours tri claim invent expect may well produc use better altern product exist previous 
final submit univers outcom hrp correspond term invent refer form amorph calcium phosphat omit import integ claim 
In view cogenc submiss univers I accept 
I give signific weight hrp question obvious 
trial and error process the complex patent formul professor reynold draw togeth three stream research lead calcium phosphopeptid technolog 
He develop process produc calcium phosphopeptid calcium phosphat complex phosphat complex studi molecular structur calcium phosphopeptid calcium phosphat complex 
He also examin develop situ model studi effici cpp phosphat complex solut enamel subsurfac lesion 
the three stream proceed independ 
It insight gain advanc one stream enabl understand approach direct stream 
professor reynold carri equilibrium bind studi suggest form phosphat complex higher pH valu might lead substanti higher yield calcium phosphopeptid per kilogram casein 
studi confirm form phosphat complex pH increas yield 
At pH valu solut becam unstabl routin precipit 
He say later learn trial error certain condit slow care addit calcium ion phosphat ion calcium phosphat would precipit 
He also engag investig three dimension structur ccp phosphat complex 
As result equilibrium bind studi molecular structur saw indic calcium phosphat bound calcium phosphopeptid pH rather pH 
howev saw result appar contradict paper professor holt 
As result began focu amorph phase calcium phosphat 
He found amorph state calcium phosphat highli pH depend acid amorph phase chemic distinct alkalin phase 
thi led investig ultim understand condit format phosphat complex would affect phase calcium phosphat complex 
He discov care titrat high concentr calcium fluorid sodium phosphat sodium hydroxid pH thorough mix could produc calcium phosphopeptid contain cluster sequenc bind amorph calcium phosphat level consider higher previous achiev 
As earli believ remineralis efficaci optim phosphat complex form pH 
He carri clinic trial surpris 
they show phosphat complex form new process far superior abil remineralis enamel substanc lesion situ calcium complex previous use 
the result situ remineralis studi emphasis import oral environ 
He realis new phosphat complex develop overcam major problem associ earlier complex 
hi analysi indic new ccp phosphat complex materi bound significantli higher concentr calcium ion phosphat ion includ hydroxid ion option ratio 
It import appreci professor reynold arriv complex patent seri trial error experi light contradictori inform teach differ direct 
By bring togeth separ stream research abl identifi invent subject complex patent understand way phosphat complex could formul prepar result improv deliveri remineralis tooth surfac 
prior art inform section OF the act submiss made nsi interpret effect ss act prior amend made patent amend act No 
the section relevantli provid for purpos act invent taken involv invent step compar prior art base unless invent would obviou person skill relev art light common gener knowledg exist patent area prioriti date relev claim whether knowledg consid separ togeth either kind inform mention subsect must consid separ 
for purpos subsect kind inform prior art inform made publicli avail singl document singl act b prior art inform made publicli avail relat document relat act relationship document act person skill relev art patent area would treat singl sourc inform inform skill person mention subsect could prioriti date relev claim reason expect ascertain understood regard relev work relev art patent area 
the refer reason expect view mean simpli question person capac use search tool method order locat inform rather whether opinion court evid reason degre expect skill person would ascertain inform 
the word could modifi requir reason expect light assess skill addresse would accord expert evid 
the languag impos requir skill addresse would done 
the test also concern individu skill addresse rather construct hypothet addresse notion qualiti attribut skill addresse 
the question address basi legal construct greatli dissimilar hypothet reason man use area law particular attribut requir skill addresse field 
the test object one limit accept particular skill addresse assert would done 
It submit univers whether document fall within ascertain cours skill person ordinari work relev field must regard relev ordinari work 
the univers say inform ascertain regard relev part particular invent process take account orient toward solut recognis problem 
the submiss correct proceed basi specif problem motiv taken account 
put anoth way said relat step hypothet journey mere refer bodi common gener knowledg relev field purpos comparison 
As matter interpret justif limit provis inform could reason expect ascertain part person ordinari work ignor circumst skill person take account pursu particular research project 
section term silent distinct 
On face capabl applic person engag work relev art also person engag undertak particular project 
the question pose section whether would obviou skill person art 
there limit type work perform 
It artifici categor exclud inform would ascertain cours direct attent use desir result 
accordingli I read limit 
ascertain the univers accept Dr mackinlay would capabl ascertain exist articl sato reynold reev latour 
howev univers say could reason expect direct particular attent 
thi obvious influenc hindsight demonstr exampl go directli peptid 
moreov clear criteria use Dr mackinlay evid select clear consist 
for exampl articl Dr holt refer Dr mackinlay origin evid 
howev Dr mackinlay conced relev 
Dr mackinlay found approxim articl consid could relev select three articl 
In addit reason would want read reev latour articl unsatisfactori reason face appear repeat matter alreadi awar 
moreov could explain follow anoth articl cite context reev latour articl 
Dr mckinnon set approach literatur search said would gone back examin literatur written prior locat reev latour articl great progress area casein research sinc date 
He also state experi period much earli experiment work properli control therefor result period like unreli 
Dr mckinnon come across reev latour articl cours work 
He doubt whether search made would brought reev latour articl 
He also say come across reynold articl would margin whether read 
In relat sato articl Dr mckinnon would regard relev base titl author 
I persuad evid skill addresse could reason expect three articl would ascertain person skill relev art march 
nor I satisfi skill addresse would expect treat relevantli singl sourc particular attent would paid 
have regard forego reason relat obvious I accept submiss complex patent invalid ground 
fals suggest A patent revok act basi patent obtain fraud fals suggest misrepresent 
nsi alleg claim complex patent obtain fals suggest 
these alleg relat letter date februari univers respons fifth report examin 
the examin object grant complex patent ground invent anticip 
An amend form claim submit univers includ requir complex form pH greater univers repres patent offic believ claim novel invent 
nsi claim letter made fals suggest repres patent attorney believ claim novel invent therebi lead grant patent 
nsi alleg represent fals inform packag alreadi made publicli avail contain integ claim complex patent 
It note statement univers form submiss legal effect amend patent claim must consid context 
the statement involv consider state prior art 
It settl law applic patent make submiss patent offic proper construct effect claim found fals suggest represent simpli submiss may later held incorrect see ici chemic polym ltd v lubrizol corp inc fca ipr 
insofar represent base belief shown fals belief one reason held 
On contrari conclus I reach issu novelti obvious meet submiss nsi 
In close address nsi sought rais question plead 
howev event view affect conclus I reach way 
fair basi section act requir complet specif must clear succinct fairli base matter describ specif 
nsi submit complex patent specif compli requir 
In lockwood secur product pti ltd v doric product pti ltd hca clr high court formul relev question whether real reason clear disclosur bodi specif claim invent broadli gener sens describ bodi specif 
anoth way question pose ask whether claim travel beyond disclosur specif olin corpor v super cartridg Co pti ltd hca clr per barwick CJ 
the submiss nsi base content product phoscal powder topoc dentac integ claim complex patent claim fairli base claim product includ amorph calcium phosphat complex irrespect manner phosphopeptid deriv 
thi argument requir unduli narrow interpret taken specif 
I reject interpret earlier reason 
In case specif consistori claus p use languag claim 
the specif descript reinforc state phosphopeptid deriv sourc 
thi read also adopt Dr mckinnon 
In view claim fairli base 
nsi also assert claim clear succinct 
howev view real ambigu lack clariti succinct claim satisfi criteria 
trade practic claim the univers claim respond engag mislead decept conduct contravent trade practic act cth tpa 
the univers also say repres good servic sponsorship approv perform characterist benefit contravent c tpa 
some trade practic claim initi brought resolv 
the remain issu concern alleg univers nsi parti made represent scientif studi conduct relat phoscal topac dentac phoscal activ ingredi show efficaci product similar equal univers product known recald product known tooth mouss recald activ ingredi 
the univers refer author support proposit must basi fact compar advertis publish compar claim ensur comparison accur see stuart v alexand alr per lockhart J makita aust pti ltd v black decker pti ltd ipr duracel australia pti ltd v union carbid australia ltd ipr per burchett J 
In colgat palmol pti ltd v rexona pti ltd alr court held mislead conduct make compar effici claim impli made scientif basi fact proper scientif basi make claim 
that case relat claim respect ingredi toothpast 
A comparison may mislead omiss materi fact would necessari render comparison fair mislead corpor put forward suffici inform dispel possibl recipi may misl 
In circumst may mislead make statement impli adequ foundat scientif knowledg justifi taken context scientif statement provid proper foundat exampl see sterl winthrop pti ltd v boot Co australia pti ltd ipr case cite therein 
the represent said made case effect product question equival effect efficaci similar led similar clinic outcom 
In addit assert concern rel dosag 
the univers say nsi parti made impli represent possess adequ scientif research data support represent 
professor daw oral biologist call nsi said understood premis assert 
He gave evid far awar scientif valid data publish support represent made nsi parti 
the nsi parti file evid answer evid professor daw except affidavit Dr mcintosh refer distribut document represent said made 
instead nsi parti reli context content statement 
the nsi parti submit consid whether represent may mislead necessari consid context statement made determin whether impli adequ foundat scientif knowledg enabl made 
nsi say necessari consid context take account like recipi inform 
confidenti exhibit A date januari 
On face appear promot document page relat phoscal entitl introduc phoscal 
It refer recald patent technolog develop professor reynold 
It explain background compani produc phoscal discuss use phoscal examin differ phoscal product contain recald 
It refer variou trial product contain phoscal potenti applic phoscal 
It contain describ foam stabil comparison made period minut 
It refer commerci advantag recald extol benefit phoscal 
It say accord one studi phoscal less recald 
It refer approxim comparison product 
the evid establish use document class type recipi 
In absenc know document context use I persuad evid professor daw establish misrepresent impli express relat phoscal recald product 
the next document reli CD relat rel merit topac tooth mouss 
It date octob email Dr mcintosh nsi dental melbourn dentist 
the email refer dentist request inform nsi believ topac effect longer period time tooth mouss 
the email refer photograph demonstr effect topac describ Dr mcintosh quit convinc 
there refer Dr mcintosh support public refer document present argument 
have regard languag use email refer belief argument I consid document misrepresent 
rather face document natur argument assert 
exhibit CD email Dr mcintosh person name naomi 
It attach file show comparison ingredi use topac tooth moos 
It state use whole phosphoprotein chemic simpler less expens use certain peptid extract protein tooth mouss advantag stabl 
It state approach advantag point 
It refer compar disadvantag product state end result clinic outcom similar topac less expens 
the email address addresse 
there suggest document scientif studi valid statement 
the email appar respons enquiri differ two product balanc answer given 
In view noth email mislead decept make fals represent 
exhibit CD fax Dr mcintosh Dr glenda harri explain similar differ product activ ingredi name phoscal use topac recald use tooth mouss 
It state product similar 
topac said stabl tooth mouss said huge import point 
In relat identifi real question name whether addit calcium phosphat clinic signific facsimil state juri still point comparison studi 
In view fax make fals represent impli scientif valid advantag nsi product activ ingredi phoscal 
exhibit CD file note date octob 
It form previou document 
It also state juri still 
the next document exhibit note refer topac tooth mouss 
the use document context appar 
It state direct comparison topac tooth moos shown equival sodium fluorid rins abil prevent cari 
again indic document view scientif valid studi 
the next document confidenti exhibit D use Dr mcintosh present pfizer australia 
there evid distribut document attend present whether document mere use note oral present 
there compar tabl set summari properti recald phoscal 
In instanc increas remineralis recald state better 
In view document characteris part sale pitch refer scientif studi 
the comparison tabl would seen advertis public assert rather factual represent exist scientif back studi statement 
final Dr daw refer confidenti exhibit E 
thi seri slide stabil studi 
In view give rise implic scientif studi support represent may made slide 
I persuad evid avail statement made mislead decept qualiti good suggest implic sound scientif back assert made document 
accordingli I dismiss trade practic claim brought univers 
conclus I satisfi reason conclus alleg unjustifi threat act made 
I find complex patent valid infring claim case made univers injunct relief 
I dismiss claim univers tpa fair trade legisl 
I reject fals suggest claim 
I resolv question appropri parti I wish hear parti question chanc consid reason 
I direct respond prepar exchang draft short minut order give effect reason appoint time hear make provis submiss outstand question 
I certifi preced two hundr number paragraph true copi reason judgment herein honour justic tamberlin 
